650 filings
Page 9 of 33
EFFECT
jmb3er n5lw9n
10 Dec 18
Notice of effectiveness
12:16am
CORRESP
4ek0ucla
4 Dec 18
Correspondence with SEC
12:00am
UPLOAD
6hfnn94yfytfa7
4 Dec 18
Letter from SEC
12:00am
S-8
p77n9rl7
7 Nov 18
Registration of securities for employees
4:57pm
8-K
yvgpl 6xsmyyx91c
7 Nov 18
Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update
12:00am
8-K
i8bq7ifdsbb3g3o
1 Oct 18
Achieve Announces Pricing of $5.6 Million Registered Direct Offering
5:11pm
424B5
56yp6dkri3 uzk8
1 Oct 18
Prospectus supplement for primary offering
5:04pm
8-K
kgckmth39xdgk 69
28 Sep 18
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects
5:27pm
8-K
7cjrc9nkktz3li0g
21 Sep 18
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
dem6w
8 Aug 18
Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update
4:10pm
8-K
863fdqza5 ka3p3aqkd
20 Jun 18
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
8:45am
424B4
kb3w1qd
15 Jun 18
Prospectus supplement with pricing info
5:24pm
EFFECT
mozve0q xog41diph8dl
14 Jun 18
Notice of effectiveness
12:00am
S-1MEF
3hgv7ja hvc363w
14 Jun 18
Registration of additional securities for an S-1
12:00am